Georg Kemmler

发表

Two New Cancer-Specific Multi-Attribute Utility Instruments: EORTC QLU-C10D and FACT-8D

Stuart Peacock, Richard Norman, John Brazier, 2016 .

Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients

Georg Kemmler, Elisabeth M. Weiss, Christian Kremser, 2005, Psychiatry Research: Neuroimaging.

Cost–utility analyses of drug therapies in breast cancer: a systematic review

Bernhard Holzner, Georg Kemmler, G. Kemmler, 2016, Breast Cancer Research and Treatment.

No deterioration of cognitive performance in an aggressive unilateral and bilateral antidepressant rTMS add-on trial.

Georg Kemmler, Alvaro Pascual-Leone, Andreas Conca, 2004, The Journal of clinical psychiatry.

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

Georg Kemmler, Elisabeth M. Weiss, Christian Humpel, 2011, Neurobiology of Aging.

Differential effect of catechol-O-methyltransferase Val158Met genotype on emotional recognition abilities in healthy men and women

Herbert Oberacher, Georg Kemmler, Walther Parson, 2007, Journal of the International Neuropsychological Society.

Brain activation patterns during a selective attention test—a functional MRI study in healthy volunteers and patients with schizophrenia

Felix M Mottaghy, Georg Kemmler, Christian Kremser, 2003, Psychiatry Research: Neuroimaging.

Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice.

Bernhard Holzner, Gerhard Rumpold, Georg Kemmler, 2010, Journal of pain and symptom management.

Impulsivity and Alcohol Dependence Treatment Completion: Is There a Neurocognitive Risk Factor at Treatment Entry?

Andreas Heinz, Georg Kemmler, A. Heinz, 2016, Alcoholism, clinical and experimental research.

Sex differences in cognitive functions

Margarete Delazer, Georg Kemmler, Elisabeth M. Weiss, 2003 .

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine

Georg Kemmler, Kurt Jellinger, K. Jellinger, 2008, Neurobiology of Aging.

Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients

Bernhard Holzner, Gerhard Rumpold, Georg Kemmler, 2009, Psycho-oncology.

Osteoarthritis After Arthroscopic Partial Meniscectomy

Georg Kemmler, G. Kemmler, K. Benedetto, 1995, The American journal of sports medicine.

Do neurooncological patients and their significant others agree on quality of life ratings?

Bernhard Holzner, Gerhard Rumpold, Georg Kemmler, 2009, Health and quality of life outcomes.